University Health Network
🇨🇦Canada
Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)
- Conditions
- PainSleepEpilepsyDepressionAnxiety
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2022-04-11
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 2000
- Registration Number
- NCT04526093
- Locations
- 🇨🇦
Toronto General Hospital, UHN, Toronto, Ontario, Canada
Partial Neuromuscular Blockade in Acute Respiratory Distress Syndrome
Not Applicable
Terminated
- Conditions
- Respiratory InsufficiencyExtracorporeal Membrane Oxygenation ComplicationNeuromuscular Blockade
- Interventions
- Drug: Neuromuscular blockade
- First Posted Date
- 2020-08-24
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 4
- Registration Number
- NCT04524585
- Locations
- 🇨🇦
University Health Network, Toronto, Ontario, Canada
Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer
Phase 2
Withdrawn
- Conditions
- Ovarian Endometrioid TumorTP53 MutationFallopian Tube CancerPrimary Peritoneal Cancer
- Interventions
- First Posted Date
- 2020-08-12
- Last Posted Date
- 2023-06-06
- Lead Sponsor
- University Health Network, Toronto
- Registration Number
- NCT04510584
- Locations
- 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
Phase 2
Recruiting
- Conditions
- Refractory CancerClassical Hodgkin LymphomaRelapsed Cancer
- Interventions
- First Posted Date
- 2020-08-12
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 37
- Registration Number
- NCT04510636
- Locations
- 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Ex-vivo Delivery of Rituximab to Prevent PTLD in EBV Mismatch Lung Transplant Recipients: A Pilot Trial
Phase 1
- Conditions
- Post-transplant Lymphoproliferative DisorderEpstein-Barr Virus Infections
- Interventions
- Biological: Rituximab
- First Posted Date
- 2020-08-11
- Last Posted Date
- 2022-08-02
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 10
- Registration Number
- NCT04507477
- Locations
- 🇨🇦
University Health Network, Toronto General Hospital, Multi-Organ Transplant, Toronto, Ontario, Canada
The Person-centered Evolution of Radiotherapy Services in Ontario Study
Not Applicable
Active, not recruiting
- Conditions
- Quality of LifeBreast Cancer
- Interventions
- Other: Quality of Life Questionnaires
- First Posted Date
- 2020-08-11
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 109
- Registration Number
- NCT04507568
- Locations
- 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Bilateral Essential Tremor Treatment With FUS
Not Applicable
Active, not recruiting
- Conditions
- Essential Tremor
- Interventions
- Procedure: Magnetic Resonance-guided Focused Ultrasound VIM Thalamotomy
- First Posted Date
- 2020-08-06
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 19
- Registration Number
- NCT04501484
- Locations
- 🇨🇦
Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada
Global CALM Implementation Study
Active, not recruiting
- Conditions
- Depression
- Interventions
- Behavioral: Managing Cancer and Living Meaningfully
- First Posted Date
- 2020-08-05
- Last Posted Date
- 2023-12-07
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 100
- Registration Number
- NCT04499690
- Locations
- 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Testing Efficacy of VR in Medical Education
Not Applicable
- Conditions
- Virtual Reality and Medical Education
- Interventions
- Other: VROther: Traditional
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2020-07-21
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 40
- Registration Number
- NCT04480489
GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma
Not Applicable
Active, not recruiting
- Conditions
- Resectable Pancreatic Cancer
- Interventions
- Drug: Modified Folforinox (mFFX)
- First Posted Date
- 2020-07-16
- Last Posted Date
- 2023-11-27
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 84
- Registration Number
- NCT04472910
- Locations
- 🇨🇦
Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦Jewish General Hospital, Montréal, Quebec, Canada
🇨🇦BC Cancer Agency Vancouver, Vancouver, British Columbia, Canada
© Copyright 2025. All Rights Reserved by MedPath